UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 造血細胞移植後の移植片対腫瘍効果の生物学 biology of the graft versus tumor effect following hematopoietic cell transplantation
2. 小児における急性リンパ芽球性白血病の治療の概要 overview of the treatment of acute lymphoblastic leukemia in children
3. 関節リウマチに対するリツキシマブおよびその他のB細胞標的療法 rituximab and other b cell targeted therapies for rheumatoid arthritis
4. 同種造血細胞移植後の肺合併症 pulmonary complications after allogeneic hematopoietic cell transplantation
5. ナイミーヘン染色体不安定症候群 nijmegen breakage syndrome

English Journal

Understanding the biology of ex vivo-expanded CD8 T cells for adoptive cell therapy: role of CD62L.

Díaz-Montero CM, Zidan AA, Pallin MF, Anagnostopoulos V, Salem ML, Wieder E, Komanduri K, Montero AJ, Lichtenheld MG.SourceDepartment of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA, diazc2@ccf.org.
Immunologic research.Immunol Res.2013 Nov 12. [Epub ahead of print]
CD62L governs the circulation of CD8+ T cells between lymph nodes and peripheral tissues, whereby the expression of CD62L by CD8+ T cells promotes their recirculation through lymph nodes. As such, CD62L participates in the fate of adoptively transferred CD8+ T cells and may control their effectivene
PMID 24218360

Colitogenic effector T cells: roles of gut-homing integrin, gut antigen specificity and γδ T cells.

Do JS, Visperas A, Freeman ML, Iwakura Y, Oukka M, Min B.SourceDepartment of Immunology/NB30, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Immunology and cell biology.Immunol Cell Biol.2013 Nov 5. doi: 10.1038/icb.2013.70. [Epub ahead of print]
Disturbance of T-cell homeostasis could lead to intestinal inflammation. Naive CD4 T cells undergoing spontaneous proliferation, a robust proliferative response that occurs under severe lymphopenic conditions, differentiate into effector cells producing Th1- and/or Th17-type cytokines and induce a c
PMID 24189163

Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation.

Ross D, Jones M, Komanduri K, Levy RB.SourceDepartments of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, Florida.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.Biol Blood Marrow Transplant.2013 Oct;19(10):1430-8. doi: 10.1016/j.bbmt.2013.06.019. Epub 2013 Jun 29.
Administration of cyclophosphamide after transplantation (post-transplantation cyclophosphamide, PTC) has shown promise in the clinic as a prophylactic agent against graft-versus-host disease (GVHD). An important issue with regard to recipient immune function and reconstitution after PTC is the exte
PMID 23819914

W5-2 Lymphopenia-induced proliferation (LIP) triggers the development of follicular helper T (T<sub>FH</sub>) cells which have a distinctive ontogeny and a critical role in aberrant B cell responses